BioScrip (BIOS) Misses Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BIOS Hot Sheet
Price: $10.80 --0%
Financial Fact:
(Loss) income before income taxes: -10.67M
Today's EPS Names:
CIX, ARIS, COHR, More
Financial Fact:
(Loss) income before income taxes: -10.67M
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
BioScrip (NASDAQ: BIOS) reported Q2 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $232.5 million versus the consensus estimate of $229.58 million.
GUIDANCE:
BioScrip sees FY2016 EPS of ($0.48)-($0.38).
For earnings history and earnings-related data on BioScrip (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
- ArcelorMittal (MT) Tops Q3 EPS by 36c
- Aris Water Solutions (ARIS) Tops Q3 EPS by 35c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
